The Operating System for Precision Longevity

The operating system
for precision longevity.

Kairos turns fragmented biological data into one persistent, clinically actionable intelligence layer — one that predicts trajectory, supports intervention design, measures response, and sharpens with every observation. Not another longevity clinic. Not a wellness app. An infrastructure layer for prevention, human performance, and measurable healthspan extension.

Read the Science Request Clinical Access
47ms p95 latency
536 validation tests
5 production models
45+ PMID priors
MIDUS & NHANES validated
45+ PMID-cited priors
OpenTelemetry instrumented
HIPAA-compliant infrastructure
Conformal prediction coverage
Why Kairos

From isolated tests
to an always-learning biological layer.

Medicine still treats biology in fragments. Kairos closes that gap through a multimodal digital twin that unifies biomarkers, proteomic signal, wearables, sleep, functional performance, imaging, and clinical context into one longitudinal engine. On top of that foundation sit agentic AI, prediction models, and continuous AutoResearch workflows that refine the system as new evidence, outcomes, and performance data accumulate. A report describes biology once. Kairos manages biology across years.

Multimodal Digital Twin

Biomarkers, proteomics, wearables, sleep, imaging, and clinical context unified in one longitudinal engine — a persistent biological memory, not another siloed report.

Agentic AI Layers

Prediction models and AutoResearch workflows that refine as new outcomes, evidence, and performance data accumulate. The system gets sharper with every case — without manual retraining cycles.

Persistent Intelligence

Not a snapshot. A living system that manages biology across years, not appointments — the engine that knows your trajectory, not just your last result.

The Problem

Population statistics do not
prescribe to individuals.

Current clinical tools operate on cohort averages. Kairos operates where clinical decisions actually happen — at the individual level.

Correlation masquerades as causation

Regression-based tools identify associations — they cannot tell you whether a protocol caused a biomarker shift or merely correlated with it. Dragonnet-level causal inference requires infrastructure most teams cannot build in-house.

60% response rates leave 40% behind

A protocol effective for the majority fails the outliers — often the patients with the highest unmet need. Individual treatment effect estimation identifies who responds before you commit to a 90-day protocol.

Point estimates carry false precision

A single predicted value is not actionable — it is overconfident. Calibrated conformal prediction intervals tell clinicians the range within which the true response will fall, at any requested confidence level.

Core Capabilities

Clinical ML infrastructure,
not another dashboard.

Five production models. One API surface. Designed to plug into your clinical workflow without rebuilding your data pipeline.

XGBoost + MAPIE

Risk Prediction

Five-class treatment response prediction with conformal prediction intervals. Every output includes a calibrated uncertainty range — never a bare point estimate.

T-Learner ITE

Treatment Effects

Individual treatment effect estimation via twin XGBoost T-Learner. Identifies which protocol produces a measurable response for this specific patient.

Dragonnet

Causal Inference

Deep causal model jointly estimates propensity and outcome, producing causal effect estimates under stated assumptions — a disciplined step beyond pure correlation in observational clinical data.

19 Biomarkers

Biological Age

Composite biological age from 19 biomarkers with gender-specific calibration. Delta-age output quantifies the gap between chronological and biological age. ICC ≥ 0.75.

Bayesian Posterior

N-of-1 Learning

Bayesian posterior updates with every blood draw. Priors encode 45+ published meta-analyses. Each observation refines the patient-specific model — no retraining.

REST API

Single API Surface

All five models accessible via one authenticated REST endpoint. Structured JSON. No proprietary SDK. GCP Cloud Run. 47ms p95 latency.

Platform Depth

The data foundation
behind every prediction.

A multi-cohort substrate structured into the core platform logic. Current integrations plus an active expansion pathway into UK Biobank-scale proteomics — visibility into organ stress, resilience, and future biological risk far beyond routine bloodwork.

500K+ Validated Subjects Multi-cohort substrate structured into core platform logic.
150K+ Mortality-Linked Cases Outcome-linked signal informing aging logic, risk architecture, disease-trajectory modeling.
31 Cohorts Integrated Diverse populations across longitudinal follow-up windows.
20 Disease Models Structured into the engine for trajectory prediction and risk stratification.
5,400 Proteins — Next Expansion UK Biobank-scale proteomic depth opening earlier visibility into organ stress and resilience.

Platform capacity across integrated cohorts and active expansion pathway. Proteomic layer activates on UK Biobank Tier-2 access, scheduled 2026.

Integration

From biomarker panel
to clinical decision — one call.

Ingest

Send patient biomarker data as structured JSON to a single authenticated endpoint. No proprietary SDK. No custom data pipeline. HIPAA-aware architecture.

Infer

Receive individual treatment effects, biological age, risk class, and Bayesian posterior — each with calibrated confidence intervals. Latency under 50ms at p95.

Learn

Each new observation updates the patient's Bayesian posterior automatically. The patient-specific model refines with every new draw — no manual retraining required.

POST /v1/predict/individual 47ms p95 
// Request
{
  "patient_id":  "pt_8a3f92",
  "biomarkers": {
    "hba1c":       5.4,
    "hsCRP":       0.8,
    "IL6":         2.1,
    "dheas":       180,
    "testosterone": 420
    // ...19 total biomarkers
  },
  "treatment": "high_dose_nad"
}

// Response — 47ms p95
{
  "ite": {
    "estimate": 0.34,
    "ci_95":   [0.18, 0.51]
  },
  "bio_age": {
    "delta":         -4.2,
    "chronological": 52
  },
  "risk_class":  "responder",
  "confidence": 0.87,
  "model_version": "v2.4.1"
}
Evidence Foundation

Built on evidence.
Updated with every observation.

Priors sourced from peer-reviewed meta-analyses. Models validated against MIDUS and NHANES cohorts. Every prediction traceable to its evidence base.

19 Biomarkers tracked
15 Treatments in registry
45+ PMID-cited priors
536 Validation tests
70+ API endpoints

Bayesian priors with provenance

Every prior in the registry is encoded with a PMID or DOI. Standard deviations are inflated 20% for conservatism.

Conformal prediction guarantees

Marginal coverage is guaranteed at the requested level without distributional assumptions. Valid on finite samples.

Cohort-calibrated correlations

Biomarker correlations and biological age slopes calibrated against MIDUS (n=7,000+) and NHANES. 20–30% real-world degradation accepted and documented.

Defensibility

What makes it defensible.

Five structural advantages that compound over time. Each cycle of prediction, intervention, and recalibration tightens the model — the moat widens with usage.

Multimodal Digital Twin Memory

Persistent biological memory rather than isolated assessments. The system knows your trajectory, not just your last result.

Agentic AI Refinement

Continuously refining model performance as new outcomes, evidence, and performance data accumulate in the system.

AutoResearch Architecture

Translating new scientific evidence into platform upgrades automatically — the system improves without manual intervention.

Closed-Loop Outcome Tracking

From prediction to intervention to recalibration — every cycle tightens the model and improves future accuracy for this specific patient.

Institutional Expansion Path

A future path into white-label, institutional, and population-intelligence models — defensible at every scale from individual to health system.

Why Population-Specific Biology Matters

The next frontier is not more data —
it is correctly calibrated data.

Meaningful biological divergence has already been observed between NHANES (United States) and KNHANES (South Korea). If baseline biology, biomarker distributions, and risk relationships differ there, they will almost certainly differ in the UAE as well. Imported one-size-fits-all modeling misprescribes populations it was never calibrated on.

Generic

Imported Models

  • One-size-fits-all
  • US/EU baseline
  • Misaligned risk thresholds
  • No local validation
Partial

Partially Adapted

  • Adjusted reference ranges
  • Limited local data
  • Incomplete divergence mapping
Kairos

Population-Calibrated

  • Population-specific baseline
  • Local biomarker distributions
  • Population-matched risk architecture
  • Continuous local refinement
Who We Serve

Precision medicine infrastructure
for every team.

For Clinicians

Longevity Clinics

Replace protocol intuition with individual-level evidence. Predict which NAD+, peptide, or hormonal protocol produces a measurable response for each patient before committing to a 90-day program.

ITE estimation Bio-age tracking N-of-1 learning
For Builders

Precision Medicine Startups

Plug-and-play ML engine behind your product. Integrate treatment effect estimation, biological age, and risk prediction via REST — without hiring a team of biostatisticians or maintaining model infrastructure.

REST API Conformal intervals Dragonnet causal
For Researchers

Contract Research Orgs

Design N-of-1 trials with Bayesian adaptive stopping rules. Every patient serves as their own control. Posterior updates reduce required sample sizes without sacrificing statistical validity.

Adaptive trials Bayesian stopping PMID-traced priors
The Big Vision

The biological operating layer
for the world.

Kairos is the opening move in a new global health category: a biological operating layer that can power premium residences, elite preventive programs, institutional partnerships, white-label clinical infrastructure, and population-scale intelligence.

Flagship Deployment

Premium Residences

Blue Continuum Residences — a clinical-grade longevity and biological management suite embedded inside premium residential buildings. Not a spa. Not a gym. A continuity layer for testing, intervention, retesting, recovery, and biological optimization. Where continuity becomes lived infrastructure.

Elite Programs

Preventive Programs

Clinical-grade biological management for high-performance individuals, executives, and athletes — where intuition gives way to measurable, individually-calibrated protocol design.

White-Label

Institutional Partnerships

Clinical infrastructure and population-intelligence models for health systems and research institutions. One engine behind many surfaces — defensible at every scale.

Origin

Where It Starts

Kairos is where precision health becomes continuity. The platform is built to serve the markets where prevention, human performance, and AI-driven medicine are becoming national agendas — not afterthoughts.

Kairos is where precision health becomes continuity.
Blue Continuum Residences is where continuity becomes lived infrastructure.

Talk to the team For clinical, institutional, and building-integration partnerships.